Application Note: Advantages of using ACQUITY PREMIER System and columns with MaxPeak HPS technology for bioanalysis of gefitinib
19 February 2021

In this application note, Waters investigates the effects of novel hybrid barrier surface technologies on metal-insensitive compounds, using gefitinib (Iressa) as a candidate molecule. The ACQUITY PREMIER System and MaxPeak HPS Columns are designed to improve the robustness and reproducibility for bioanalysis of gefitinib.